![](/wp-content/uploads/2023/08/Screenshot-2023-08-07-at-6.15.30-PM.png)
$599
MannKind and Viatris Q2 ’23 Earnings Updates
Two cardiometabolic-related news items have been observed: MannKind (press release) and Viatris (press release; slides) hosted their respective Q2 ‘23 earnings calls. Below, FENIX provides highlights and insights into the respective news items.